---

title: 'Ectopic Pregnancy and Methotrexate'
authors:
    - 'Michelle Lin, MD'
created: 2011/11/11
updates:
    - 2011/11/11
categories:
    - OBGYN
drugs: Methotrexate

---


# Ectopic Pregnancy and Methotrexate

-   2% of all first-trimester pregnancies and 6% of all pregnancy-related deaths
-   18% of patients who present with first-trimester bleeding or abdominal pain in the Emergency Department
-   Risk factors

  - Prior tubal, pelvic, or abdominal surgery
  - Genital infections leading to pelvic inflammatory disease
  - Prior ectopic pregnancy
  - In utero exposure to diethylstilbestrol (DES)
  - History of infertility
  - Use of assisted reproductive technologies (in vitro fertilization)
  - Tobacco use

## Methotrexate (MTX)

**Background**

-   Dihydrofolate reductase inhibitor
-   Overall success rate for treating ectopic pregnancy = 71-94%
-   Success rate of single-dose MTX for B-hCG &gt; 5,000 mIU/mL = 85.7% 

**Side Effects**
-   Abdominal pain
-   Nausea/vomiting
-   Stomatitis    

## Eligibility / Contraindications for MTX in Ectopic Pregnancy

**Eligibility Criteria:**

-   High clinical suspicion or confirmed ectopic pregnancy,
-   Hemodynamically stable,
-   Unruptured mass,
-   Able to comply with close follow-up, **AND**
-   Normal creatinine, liver transaminases, WBC, hematocrit, and platelet counts 

**Contraindications:**
-   Breastfeeding
-   Overt or lab evidence of immunodeficiency
-   Alcoholism, alcoholic or chronic liver disease
-   Preexisting blood dyscrasias or significant anemia 
-   Known sensitivity to MTX
-   Active pulmonary disease
-   Peptic ulcer disease
-   Hepatic, renal, or hematologic dysfunction
-   Gestational sac &gt; 3.5 cm on U/S (relative contraindication) 
-   Embryonic cardiac motion on U/S (relative contraindication) 

## Single-Dose Regimen

-   <span class="drug">Methotrexate</span> 50 mg/m2 IM on Day 1

**Follow up with obstetrician to:**
-   Measure B-hCG on Days 4 and 7
-   Check for 15% B-hCG decrease between days 4 and 7
-   Measure B-hCG weekly until non-pregnant level
-   If B-hCG dose not decrease by &gt;15% as expected, re-dose 50 mg/m2 IM and repeat B-hCG on days 4 and 7 after 2nd dose. 

## Alternative Regimens

-   **Two-Dose** and **Fixed Multidose** regimens available as proposed by ACOG guidelines - Consider for B-hCG level &gt; 5,000 mIU/mL

## References

-   [ACOG Practice Bulletin No. 94:Medical management of ectopic pregnancy. Obstet Gynecology. 2008; 111(6):1479-85.](http://www.ncbi.nlm.nih.gov/pubmed/18515537)
